About Ritelth
Ritelth is a Healthcare company based in Thane (India) founded in 2016. Supplying pharmaceutical medicines and drugs for domestic and international markets from India. Ritelth offers products and services including Asings-MR and Asings-P. Its focus areas include Pharmaceuticals, Medicine Manufacturing, Branded Medicines and Distribution Services. Its legal entity in India is Ritelth Medipharma Private Limited (U24100MH2016PTC272679).
Company details
Ritelth Medipharma Pvt. Ltd. is recognized as a pharmaceutical company based in Mumbai, Maharashtra, India, where medicines and drugs are supplied for both domestic and international markets. It was established in 2016 under the Indian Companies Act, 1956, and is supported by professionals with approximately 20 years of experience. Quality products adhering to GMP and WHO standards are provided to reduce healthcare costs globally. The company operates with a focus on collaborative distribution and maintains a commitment to affordable branded medicines.
- Headquarters Thane, India
- SectorsHealthcare
- Legal Name Ritelth Medipharma Private Limited
- Date of Incorporation 04 Feb, 2016
- Jurisdiction Thane, Maharashtra, India
- Annual Revenue₹21,088
FY 2023 · -49% YoY
- Net Loss-₹2 Lakh
FY 2023 · -936% margin
- EBITDA₹21,088
FY 2023 · 100% margin
Associated legal entities of Ritelth
Ritelth operates through Ritelth Medipharma Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2023) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Ritelth Medipharma Private Limited CIN U24100MH2016PTC272679 | Active | 04 Feb 2016 | Thane, Maharashtra | ₹0.0 Cr | 3 | View details |
Products & Services of Ritelth
Ritelth offers a comprehensive portfolio of products and services, including Asings-MR and Asings-P.
This pharmaceutical product is supplied for health purposes in domestic and international markets.
This pharmaceutical product is provided as part of the company's range for addressing various health needs.
Board of directors of Ritelth Medipharma Private Limited (Ritelth)
Ritelth Medipharma Private Limited is the primary company behind Ritelth. The board of Ritelth Medipharma Private Limited currently have 3 directors; the longest-serving is Hemant Sajanrao Shewale, appointed in 2016.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Hemant Sajanrao Shewale DIN 07369654 | Director | 04 Feb 2016 | 10 yrs 8 mo | Ritelth Medipharma Private Limited |
| Balasaheb Tukaram Mohite DIN 07411008 | Director | 04 Feb 2016 | 10 yrs 8 mo | Ritelth Medipharma Private Limited |
| Krishna Bhaskar Nimsakhare DIN 02504597 | Director | 04 Feb 2016 | 10 yrs 8 mo | Ritelth Medipharma Private Limited |
Financials of Ritelth
Figures of Ritelth Medipharma Private Limited, the primary company behind Ritelth, for FY 2023. Revenue was ₹21,088 (-49% year on year). Net loss was -₹2 Lakh (-936% margin). EBITDA was ₹21,088 (100% margin). Revenue has grown at a compounded annual rate of -88% over three years and -72% over five years.
- ₹21,088Revenue · FY 2023 · -49% YoY
- -₹2 LakhNet loss · -936% margin
- ₹21,088EBITDA · 100% margin
- ₹3 LakhPaid-up capital
- -88%Revenue CAGR, 3 years
- -72%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Ritelth Medipharma Private Limited are on its company page.
Detailed financial statements for Ritelth
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Ritelth
Ritelth was founded in 2016.
Ritelth is headquartered in Thane, India. It is registered at Thane, Maharashtra, India.
The primary company behind Ritelth, Ritelth Medipharma Private Limited, reported revenue of ₹21,088 for FY 2023, down 49% year on year.
Ritelth Medipharma Pvt. Ltd. is recognized as a pharmaceutical company based in Mumbai, Maharashtra, India, where medicines and drugs are supplied for both domestic and international markets. It was established in 2016 under the Indian Companies Act, 1956, and is supported by professionals with approximately 20 years of experience. Quality products adhering to GMP and WHO standards are provided to reduce healthcare costs globally. The company operates with a focus on collaborative distribution and maintains a commitment to affordable branded medicines.
Ritelth offers Asings-MR and Asings-P.
Ritelth operates through Ritelth Medipharma Private Limited.
The legal entities of Ritelth currently have 3 directors, including Hemant Sajanrao Shewale, Balasaheb Tukaram Mohite, Krishna Bhaskar Nimsakhare.